Corresponding Author: Kathryn Whitaker, MD, Division of Infectious Diseases, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104 (Kathryn.Whitaker@pennmedicine.upenn.edu).
Conflict of Interest Disclosures: None reported.
Additional Contributions: We thank the patient for providing permission to share his information. We would also like to thank Eileen Shanahan, MD (Pathology Associates of Princeton), for kindly providing the histopathology images and Laurel Glaser, MD, PhD (Department of Pathology and Laboratory Medicine, University of Pennsylvania), for her input in the preparation of the report. Neither of these individuals received any compensation for their contributions.
4.Trecarichi
EM , Di Meco
E , Mazzotta
V , Fantoni
M . Tuberculous spondylodiscitis.
Eur Rev Med Pharmacol Sci. 2012;16(suppl 2):58-72.
PubMedGoogle Scholar 8.Darbyshire
J ; Medical Research Council Working Party on Tuberculosis of the Spine. Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery.
Int Orthop. 1999;23(2):73-81. doi:
10.1007/s002640050311PubMedGoogle ScholarCrossref 9.Nahid
P , Dorman
SE , Alipanah
N ,
et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis.
Clin Infect Dis. 2016;63(7):e147-e195. doi:
10.1093/cid/ciw376PubMedGoogle ScholarCrossref